Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Designed Proteins as Novel Imaging Reagents in Living Escherichia coli.

Pratt SE, Speltz EB, Mochrie SG, Regan L.

Chembiochem. 2016 Sep 2;17(17):1652-7. doi: 10.1002/cbic.201600252. Epub 2016 Jul 26.

PMID:
27304706
2.

Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activity.

Campbell RM, Anderson BD, Brooks NA, Brooks HB, Chan EM, De Dios A, Gilmour R, Graff JR, Jambrina E, Mader M, McCann D, Na S, Parsons SH, Pratt SE, Shih C, Stancato LF, Starling JJ, Tate C, Velasco JA, Wang Y, Ye XS.

Mol Cancer Ther. 2014 Feb;13(2):364-74. doi: 10.1158/1535-7163.MCT-13-0513. Epub 2013 Dec 19.

3.

Efficacy of low-dose oral metronomic dosing of the prodrug of gemcitabine, LY2334737, in human tumor xenografts.

Pratt SE, Durland-Busbice S, Shepard RL, Donoho GP, Starling JJ, Wickremsinhe ER, Perkins EJ, Dantzig AH.

Mol Cancer Ther. 2013 Apr;12(4):481-90. doi: 10.1158/1535-7163.MCT-12-0654. Epub 2013 Jan 31.

4.

Human carboxylesterase-2 hydrolyzes the prodrug of gemcitabine (LY2334737) and confers prodrug sensitivity to cancer cells.

Pratt SE, Durland-Busbice S, Shepard RL, Heinz-Taheny K, Iversen PW, Dantzig AH.

Clin Cancer Res. 2013 Mar 1;19(5):1159-68. doi: 10.1158/1078-0432.CCR-12-1184. Epub 2013 Jan 16.

5.

Quantification of gemcitabine incorporation into human DNA by LC/MS/MS as a surrogate measure for target engagement.

Wickremsinhe ER, Lutzke BS, Jones BR, Schultz GA, Freeman AB, Pratt SE, Bones AM, Ackermann BL.

Anal Chem. 2010 Aug 1;82(15):6576-83. doi: 10.1021/ac100984h.

PMID:
20698580
6.

Prescriber profiling.

Pratt SE.

Ann Intern Med. 2008 Jan 1;148(1):81-2. No abstract available.

PMID:
18166762
7.

Time course of insulin sensitivity and skeletal muscle glycogen synthase activity after a single bout of exercise in horses.

Pratt SE, Geor RJ, Spriet LL, McCutcheon LJ.

J Appl Physiol (1985). 2007 Sep;103(3):1063-9. Epub 2007 Jun 21.

8.
9.

Effects of prior exercise on components of insulin signalling in equine skeletal muscle.

McCutcheon LJ, Geor RJ, Pratt SE, Martineau E, Ho K.

Equine Vet J Suppl. 2006 Aug;(36):330-4.

PMID:
17402442
10.

Repeatability of 2 methods for assessment of insulin sensitivity and glucose dynamics in horses.

Pratt SE, Geor RJ, McCutcheon LJ.

J Vet Intern Med. 2005 Nov-Dec;19(6):883-8.

11.

Evaluation of the binding of the tricyclic isoxazole photoaffinity label LY475776 to multidrug resistance associated protein 1 (MRP1) orthologs and several ATP- binding cassette (ABC) drug transporters.

Dantzig AH, Shepard RL, Pratt SE, Tabas LB, Lander PA, Ma L, Paul DC, Williams DC, Peng SB, Slapak CA, Godinot N, Perry WL 3rd.

Biochem Pharmacol. 2004 Mar 15;67(6):1111-21.

PMID:
15006547
12.

Characterization and application of a vinblastine-selected CACO-2 cell line for evaluation of p-glycoprotein.

Laska DA, Houchins JO, Pratt SE, Horn J, Xia X, Hanssen BR, Williams DC, Dantzig AH, Lindstrom T.

In Vitro Cell Dev Biol Anim. 2002 Jul-Aug;38(7):401-10.

PMID:
12534340
13.

Identification and characterization of the canine multidrug resistance-associated protein.

Ma L, Pratt SE, Cao J, Dantzig AH, Moore RE, Slapak CA.

Mol Cancer Ther. 2002 Dec;1(14):1335-42.

14.

Expression of multidrug resistance-associated protein 2 (MRP2) in normal human tissues and carcinomas using tissue microarrays.

Sandusky GE, Mintze KS, Pratt SE, Dantzig AH.

Histopathology. 2002 Jul;41(1):65-74.

PMID:
12121239
15.

Evaluation of an in vitro coculture model for the blood-brain barrier: comparison of human umbilical vein endothelial cells (ECV304) and rat glioma cells (C6) from two commercial sources.

Scism JL, Laska DA, Horn JW, Gimple JL, Pratt SE, Shepard RL, Dantzig AH, Wrighton SA.

In Vitro Cell Dev Biol Anim. 1999 Nov-Dec;35(10):580-92.

PMID:
10614867
16.

73-year-old woman with weakness and falls.

Pratt SE, Williams AW.

Mayo Clin Proc. 1999 Jan;74(1):73-6. No abstract available.

PMID:
9987538
17.

The fragment coalescence model.

Llope WJ, Pratt SE, Frazier N, Pak R, Craig D, Gualtieri EE, Hannuschke SA, Stone NT, Vander Molen AM, Westfall GD, Yee J, Lacey RA, Lauret J, Mignerey AC, Russ DE.

Phys Rev C Nucl Phys. 1995 Oct;52(4):2004-2012. No abstract available.

PMID:
9970716
18.
19.

Differential glycosylation of the glucose transporter coincides with enhanced sugar transport in respiration deficient cells.

Pratt SE, Germinario RJ.

Biochem Biophys Res Commun. 1994 May 16;200(3):1313-20.

PMID:
8185581
20.
22.

The heat-stable cytosolic factor that promotes glucocorticoid receptor binding to DNA is neither thioredoxin nor ribonuclease.

Tienrungroj W, Pratt SE, Grippo JF, Holmgren A, Pratt WB.

J Steroid Biochem. 1987 Nov;28(5):449-57.

23.

The role of sulfhydryl groups in permitting transformation and DNA binding of the glucocorticoid receptor.

Tienrungroj W, Meshinchi S, Sanchez ER, Pratt SE, Grippo JF, Holmgren A, Pratt WB.

J Biol Chem. 1987 May 25;262(15):6992-7000.

24.

Targeting errors and reduced oculomotor range following ablations of the superior colliculus or pretectum/thalamus.

Keating EG, Kenney DV, Gooley SG, Pratt SE, McGillis SL.

Behav Brain Res. 1986 Dec;22(3):191-210.

PMID:
3790242
25.

An X-autosome fusion chromosome of Caenorhabditis elegans.

Sigurdson DC, Herman RK, Horton CA, Kari CK, Pratt SE.

Mol Gen Genet. 1986 Feb;202(2):212-8.

PMID:
3458021
26.

Evaluation of fenbendazole as an extended anthelmintic treatment regimen for swine.

Corwin RM, Pratt SE, Muser RK.

J Am Vet Med Assoc. 1984 Jul 1;185(1):58-9.

PMID:
6746372
27.

Anthelmintic effect of febantel/praziquantel paste in dogs and cats.

Corwin RM, Pratt SE, McCurdy HD.

Am J Vet Res. 1984 Jan;45(1):154-5.

PMID:
6703448
28.

Removing the superior colliculus silences eye movements normally evoked from stimulation of the parietal and occipital eye fields.

Keating EG, Gooley SG, Pratt SE, Kelsey JE.

Brain Res. 1983 Jun 13;269(1):145-8. No abstract available.

PMID:
6871695
29.

Effect of febantel against Ancylostoma caninum and Trichuris vulpis infections in dogs.

Corwin RM, McCurdy HD, Pratt SE.

Am J Vet Res. 1982 Jun;43(6):1100-2.

PMID:
7103181
30.

Prevalence of Dirofilaria immitis and Dipetalonema reconditum infections in Missouri dogs.

Pratt SE, Corwin RM, Selby LA, Rhoades JD.

J Am Vet Med Assoc. 1981 Sep 15;179(6):592-3.

PMID:
7196395
31.

Relative efficacies of pyrantel tartrate and pyrantel citrate against Oesophagostomum sp in swine.

Pratt SE, Brauer MA, Corwin RM.

Am J Vet Res. 1981 May;42(5):871-2.

PMID:
7258809
32.

Dirofilariasis in a captive wolf pack.

Pratt SE, Mall JJ, Rhoades JD, Hertzog RE, Corwin RM.

Vet Med Small Anim Clin. 1981 May;76(5):698-9. No abstract available.

PMID:
6913305
33.

Dose titration of oxfendazole against common nematodes of swine.

Corwin RM, Kennedy JA, Pratt SE.

Am J Vet Res. 1979 Feb;40(2):297-8.

PMID:
464370
34.

Antagonistic effect of zinc on increased urine delta-aminolevulinic acid excretion in lead-intoxicated rats.

Thawley DG, Pratt SE, Selby LA.

Environ Res. 1978 Apr;15(2):218-26. No abstract available.

PMID:
668653

Supplemental Content

Loading ...
Support Center